MAPT and early-onset autosomal dominant Alzheimer disease: The level of tau protein phosphorylated at position P217 (P217 tau) in blood plasma also demonstrated the potential to be used in differential diagnostics of neurodegenerative disorders, primarily Alzheimer’s disease [11].